Rachel Humphrey reports a stock award at Pyxis Oncology
By AlphaYouPublished Form 4
HUMPHREY RACHEL
Reporting filer
Rachel Humphrey reports a stock award, not an open-market purchase or sale, in Pyxis Oncology, Inc.. Form 4 filed Nov 6, 2026 lists 1 entry.
- Disclosed
- Nov 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | HUMPHREY RACHEL | 2026-11-06 | A | Grant or award | 34500 | 0 | 34,500 | 0 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- HUMPHREY RACHEL
- Date
- 2026-11-06
- Code
- A
- Action
- Grant or award
- Quantity
- 34500
- Price
- 0
- Following holdings
- 34,500
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 1.66
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 34500
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-06
- underlying Security Title: Common Stock
- underlying Security Shares: 34500
- shares Owned Following Transaction: 34500
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- HUMPHREY RACHEL: Director.
- F1: The shares subject to this option will vest in equal monthly installments through December 31, 2026, subject to the reporting person's continued service through the applicable vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.